Managing MRSA in an acute setting means combining strict infection‑prevention measures with appropriate diagnosis, antimicrobial therapy, and careful communication/monitoring.

Core components in an acute setting

In practice, “managing MRSA” on a ward or ICU usually includes:

  • Rapid identification and risk assessment
  • Isolation and contact precautions
  • Correct sampling and lab confirmation
  • Appropriate IV/oral antibiotics and source control
  • Environmental cleaning and equipment decontamination
  • Staff, patient, and family education
  • Documentation, alerts, and handover

Below is how this typically looks at the bedside.

1. Initial assessment and triage

When a patient presents with suspected or confirmed MRSA:

  • Risk assessment
    • Review history of MRSA colonisation/infection, recent hospitalisation, nursing‑home stay, dialysis, indwelling devices, recent surgery, or broad‑spectrum antibiotics.
    • Assess severity (e.g., sepsis criteria, organ dysfunction, pneumonia, extensive SSTI, bacteremia, endocarditis).
  • Screening and diagnostic tests
    • Take appropriate cultures: wound swabs, blood cultures (before antibiotics if possible), sputum, urine, catheter tips as indicated.
    • Consider screening swabs (e.g., nares, groin, axilla, perineum) according to local policy for high‑risk patients or during outbreaks.

2. Infection‑prevention and isolation

In acute care, MRSA management is as much about protecting other patients as treating the index patient.

  • Standard precautions for all patients
    • Hand hygiene before and after every patient contact, and before/after glove use.
    • Use of gloves, gowns, masks/eye protection when contact with blood/body fluids is anticipated.
  • Contact precautions for MRSA‑positive patients
    • Nurse in a single room with dedicated toilet if available; cohort only if policy allows and organisms are matched.
    • Wear gloves and gowns on room entry; remove and perform hand hygiene before exit.
    • Limit transport outside the room to essential procedures; ensure wounds/devices are covered and the patient performs hand hygiene.
  • Signage and alerts
    • Clear door signage indicating contact precautions (without breaching confidentiality in public areas).
    • Electronic/record alerts so future admissions trigger early precautions.

3. Antimicrobial therapy and source control

Management depends on the clinical syndrome and severity.

  • Empiric therapy when MRSA is likely
    • For serious infections (e.g., sepsis, pneumonia requiring ICU, complicated SSTI, suspected endocarditis): start IV anti‑MRSA agents as per local guidelines (commonly vancomycin, or alternatives like linezolid, daptomycin, etc., depending on site of infection and renal function).
    • Tailor therapy once culture and susceptibility results return.
  • Syndrome‑specific points (examples)
    • Skin/soft‑tissue infections: incision and drainage when appropriate; combine with systemic antibiotics for moderate–severe disease or systemic features.
    • Pneumonia: cover MRSA empirically in severe community‑acquired or hospital‑acquired cases where risk factors are present, then de‑escalate if cultures negative.
    • Bacteremia/endocarditis: aggressive IV therapy, echocardiography, remove/replace infected lines or devices.
  • Therapeutic drug monitoring
    • For agents like vancomycin, monitor levels, renal function, and adjust dosing according to local protocols.

4. Decolonisation (where indicated)

In acute settings, decolonisation is usually a targeted, protocol‑driven intervention rather than for everyone.

  • Typical regimen
    • Intranasal mupirocin ointment for a defined course (e.g., 5 days).
    • Daily chlorhexidine body wash or wipes.
    • Sometimes additional hair washing or oral decolonisation depending on policy.
  • When considered
    • Pre‑operative patients (e.g., cardiac, orthopaedic surgery).
    • During outbreaks or in high‑risk units (ICU, transplant).
    • Recurrent MRSA infections where decolonisation has a good chance of success.

5. Environmental cleaning and equipment

Because MRSA can persist on surfaces, environmental measures are essential in acute care.

  • Routine and terminal cleaning
    • Use approved disinfectants (often chlorine‑based or equivalent) for daily cleaning of high‑touch surfaces (bed rails, tables, monitors).
    • Terminal clean the room after patient discharge, including curtains, equipment, and sometimes enhanced disinfection (e.g., hydrogen peroxide vapour or UV where available).
  • Equipment management
    • Dedicate non‑critical equipment (stethoscope, BP cuff, thermometer) to the patient whenever possible.
    • If items must be shared, clean and disinfect between patients according to protocol.

6. Staff, patient, and family education

Managing MRSA also means managing anxiety, behaviour, and understanding.

  • Staff
    • Regular training on hand hygiene, PPE use, and current MRSA policies.
    • Clear guidance on when staff screening or work restrictions are needed (usually only in outbreak or high‑risk scenarios).
  • Patients and families
    • Explain what MRSA is, the difference between colonisation and infection, and why precautions are in place.
    • Reinforce hand hygiene, respiratory etiquette, and any restrictions on visitors where applicable.
    • Provide written information leaflets where possible.

7. Documentation, communication, and follow‑up

To avoid fragmented care, MRSA management must be clearly documented and communicated.

  • In‑hospital documentation
    • Record: sites of infection/colonisation, culture results, antibiotics (drug, dose, duration), isolation status, and any adverse events.
    • Note any decolonisation regimen and response.
  • Handover and discharge planning
    • Inform receiving wards, rehab facilities, or nursing homes about MRSA status and any ongoing precautions or therapy.
    • Ensure discharge summaries highlight MRSA for future admissions and primary‑care follow‑up.
    • Provide patient with advice on wound care, hygiene, and what to do if signs of infection recur.
  • Surveillance and quality improvement
    • Participation in hospital surveillance of MRSA rates, bloodstream infections, and compliance with hand hygiene/contact precautions.
    • Root‑cause analyses for serious MRSA events or clusters and feedback into practice.

8. Putting it together: a quick ward‑level example

Imagine a 72‑year‑old with a large leg abscess and fever admitted from a nursing home:

  1. Triage flags prior MRSA history; the patient goes straight into a single room, and contact precautions start immediately.
  2. The team takes wound and blood cultures, assesses for sepsis, and orders labs and imaging.
  3. Empiric IV vancomycin (plus Gram‑negative coverage according to local policy) is started; the abscess is surgically drained.
  4. Nursing staff use dedicated equipment, perform strict hand hygiene, and document isolation status and antibiotics in the chart.
  5. Environmental services perform enhanced daily cleaning of the room.
  6. Once cultures confirm MRSA and sensitivities, therapy is fine‑tuned and later stepped down to an appropriate oral agent to complete the course.
  7. Before discharge, the team decides whether to attempt decolonisation, educates the patient and family, and clearly documents MRSA status in the discharge summary.

Do you need this framed more for nursing care plans, for a medical/clinical exam answer, or for patient‑friendly education?